Inventor · disambiguated record
Mary L. Disis
Also filed as: DISIS MARY L
27 granted patents·9 pending applications·1,331 citations·filing 1995–2023
97Inventor score
Files withUNIV WASHINGTON17MAYO FOUND MEDICAL EDUCATION & RES6UNIV WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION5DISIS MARY L2ASTON SCI INC1
Top patents by PatentIndex Score
36 records- 0198US5869445AMethods for eliciting or enhancing reactivity to HER-2/neu proteinUNIV WASHINGTON·Filed 1996·Granted Feb 9, 1999·287 cites·4 claims
- 0298US5801005AImmune reactivity to HER-2/neu protein for diagnosis of malignancies in which the HER-2/neu oncogene is associatedUNIV WASHINGTON·Filed 1995·Granted Sep 1, 1998·296 cites·7 claims
- 0398US5726023AImmune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associatedUNIV WASHINGTON·Filed 1995·Granted Mar 10, 1998·181 cites·20 claims
- 0496US5846538AImmune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the her-2/neu oncogene is associatedUNIV WASHINGTON·Filed 1995·Granted Dec 8, 1998·122 cites·6 claims
- 0594US5876712AImmune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associatedUNIV WASHINGTON·Filed 1995·Granted Mar 2, 1999·127 cites·7 claims
- 0692US10556943B2HLA-DR binding peptides and their usesMAYO FOUND MEDICAL EDUCATION & RES·Filed 2016·Granted Feb 11, 2020·16 cites·10 claims
- 0792US8216789B2Diagnostic panel of cancer antibodies and methods for useDISIS MARY L·Filed 2009·Granted Jul 10, 2012·71 cites·8 claims
- 0888US7655239B2Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associatedUNIV WASHINGTON·Filed 2007·Granted Feb 2, 2010·2 cites·8 claims
- 0988US6075122AImmune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associatedUNIV WASHINGTON·Filed 1995·Granted Jun 13, 2000·36 cites·2 claims
- 1084US7547681B2Surface receptor antigen vaccinesUNIV WASHINGTON·Filed 2004·Granted Jun 16, 2009·12 cites·11 claims
- 1184US6734172B2Surface receptor antigen vaccinesPACIFIC NORTHWEST RES INST·Filed 1999·Granted May 11, 2004·60 cites·7 claims
- 1282US6664370B2Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associatedUNIV WASHINGTON·Filed 1999·Granted Dec 16, 2003·35 cites·48 claims
- 1379US6180114B1Therapeutic delivery using compounds self-assembled into high axial ratio microstructuresUNIV WASHINGTON·Filed 1998·Granted Jan 30, 2001·57 cites·71 claims
- 1476US11464839B2Methods and vaccines for inducing immune responses to multiple different MHC moleculesMAYO FOUND MEDICAL EDUCATION & RES·Filed 2016·Granted Oct 11, 2022·1 cites·16 claims
- 1575US9060961B2Molecules and methods for treatment and detection of cancerDISIS MARY L·Filed 2007·Granted Jun 23, 2015·6 cites·36 claims
- 1674US2010087621A1Immune reactivity to her-2/neu protein for diagnosis and treatment of malignancies in which the her-2/neu oncogene is associatedUNIV WASHINGTON·Filed 2009·Application pending·0 cites
- 1773US12042531B2Breast and ovarian cancer vaccinesUNIV WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION·Filed 2021·Granted Jul 23, 2024·0 cites·9 claims
- 1872US11185578B1Breast and ovarian cancer vaccinesUNIV WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION·Filed 2021·Granted Nov 30, 2021·0 cites·9 claims
- 1972US2023357718A1Methods and materials for expanding antigen-specific t cells in cultureMAYO FOUND MEDICAL EDUCATION & RES·Filed 2023·Application pending·0 cites
- 2070US11160853B2Breast and ovarian cancer vaccinesUNIV WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION·Filed 2019·Granted Nov 2, 2021·0 cites·13 claims
- 2166US2023098624A1Methods and vaccines for inducing immune responses to multiple different mhc moleculesMAYO FOUND MEDICAL EDUCATION & RES·Filed 2022·Application pending·0 cites
- 2263US11739296B2Methods and materials for expanding antigen-specific T cells in cultureMAYO FOUND MEDICAL EDUCATION & RES·Filed 2020·Granted Aug 29, 2023·0 cites·19 claims
- 2360US7247703B2Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associatedUNIV WASHINGTON·Filed 2003·Granted Jul 24, 2007·7 cites·5 claims
- 2460US2006008479A1Methods and compositions to generate immunity in humans against self tumor antigens by immunization with homologous foreign proteinsUNIV WASHINGTON·Filed 2005·Application pending·0 cites
- 2560US2024183856A1Her2 vaccine compositionASTON SCI INC·Filed 2022·Application pending·0 cites
- 2658US8524491B2Compounds for eliciting or enhancing immune reactivity to HER-2/neu protein for prevention or treatment of malignancies in which the HER-2/neu oncogene is associatedCHEEVER MARTIN A·Filed 2009·Granted Sep 3, 2013·0 cites·10 claims
- 2757US10647961B2Methods and materials for expanding antigen-specific T cells in cultureMAYO FOUND MEDICAL EDUCATION & RES·Filed 2016·Granted May 12, 2020·0 cites·18 claims
- 2857US2010310640A1Hla-dr binding peptides and their usesKNUTSON KEITH L·Filed 2008·Application pending·0 cites
- 2956US6942862B2Methods and compositions to generate immunity in humans against self tumor antigens by immunization with homologous foreign proteinsUNIV WASHINGTON·Filed 1998·Granted Sep 13, 2005·7 cites·3 claims
- 3055US2014377340A1Hla-dr binding peptides and their usesMAYO FOUNDATION·Filed 2014·Application pending·0 cites
- 3154US7601697B2Compounds for eliciting or enhancing immune reactivity to HER-2/neu protein for prevention or treatment of malignancies in which the HER-2/neu oncogene is associatedUNIV WASHINGTON·Filed 2005·Granted Oct 13, 2009·0 cites·1 claims
- 3251US10293035B2Breast and ovarian cancer vaccinesUNIV WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION·Filed 2015·Granted May 21, 2019·0 cites·12 claims
- 3345US6953573B1Compounds for eliciting or enhancing immune reactivity to HER-2/neu protein for prevention or treatment of malignancies in which the HER-2/neu oncogene is associatedUNIV WASHINGTON·Filed 1998·Granted Oct 11, 2005·8 cites·3 claims
- 3439US2016209414A1Compositions and methods for the diagnosis and treatment of breast cancerUNIV WASHINGTON CT COMMERCIALI·Filed 2015·Application pending·0 cites
- 3538US10759836B2Cancer vaccine compositions and methods of use thereofUNIV WASHINGTON·Filed 2015·Granted Sep 1, 2020·0 cites·11 claims
- 3636US2017266269A1Methods of identifying antigens for vaccinesUNIV WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Mary L. Disis files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →